- Investing Ideas
- /
- Global Top Stock Picks from Analysts
Global Top Stock Picks from Analysts
Results
4229
0 new
Companies which are more than 50% undervalued based on analyst price target.
4,229 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
A005930 | ₩53,600.00 | 0.9% | -31.7% | ₩361.7t | ₩81,362.86 | PE12.6x | E12.3% | 2.7% | Tech | ||
A000660 | ₩170,100.00 | -2.8% | 20.2% | ₩116.1t | ₩257,190.49 | PE11.2x | E34.8% | 0.7% | Semiconductors | ||
1299 | HK$56.70 | 3.8% | -16.7% | HK$610.1b | HK$92.99 | PE16.3x | E13.9% | 2.9% | Insurance | ||
512599 | ₹2,401.85 | -0.7% | -14.6% | ₹2.8t | ₹4,255.00 | PE51.3x | E33.4% | 0.05% | Capital Goods | ||
1024 | HK$43.05 | -4.8% | -18.0% | HK$184.9b | HK$66.09 | PE11.6x | E16.9% | n/a | Media | ||
RWE | €28.46 | 0.5% | -30.7% | €21.2b | €43.14 | PE7.5x | E-10.3% | 3.9% | Utilities | ||
BIIB | US$149.02 | 1.1% | -42.8% | US$21.7b | US$244.02 | PE13.4x | E13.6% | n/a | Pharmaceuticals & Biotech | ||
PRU | UK£6.33 | -0.2% | -27.4% | UK£16.8b | UK£11.47 | PE24.1x | E27.3% | 2.6% | Insurance | ||
DVN | US$31.24 | 2.4% | -31.7% | US$20.5b | US$50.12 | PE6x | E-4.7% | 4.6% | Energy | ||
ADANIGREEN | ₹1,064.25 | -0.9% | -31.8% | ₹1.7t | ₹1,966.25 | PE166.7x | E60.6% | n/a | Utilities | ||
BGNE | US$181.62 | 3.9% | 1.2% | US$19.3b | US$280.92 | PS6x | E73.3% | n/a | Pharmaceuticals & Biotech | ||
3993 | HK$5.34 | -2.7% | 25.6% | HK$149.0b | HK$8.38 | PE7.6x | E6.9% | 3.0% | Materials | ||
MDB | US$243.00 | -0.8% | -41.7% | US$18.1b | US$379.30 | PS9.4x | E12.6% | n/a | Software | ||
HEIO | €57.55 | -0.7% | -25.1% | €16.3b | €104.00 | PE30.3x | n/a | 3.0% | Food, Beverage & Tobacco | ||
MRNA | US$40.27 | 1.8% | -59.2% | US$15.5b | US$74.19 | PS3x | E16.0% | n/a | Pharmaceuticals & Biotech | ||
EVO | SEK 822.40 | -9.7% | -31.5% | SEK 169.9b | SEK 1,335.95 | PE12.8x | E10.6% | 3.7% | Consumer Services | ||
RPRX | US$25.23 | 3.9% | -9.8% | US$14.9b | US$41.53 | PE9.8x | E6.3% | 3.3% | Pharmaceuticals & Biotech | ||
8113 | JP¥1,292.99 | -2.0% | -23.8% | JP¥2.3t | JP¥4,909.00 | PE26.9x | E10.4% | 3.4% | Household | ||
SMMT | US$19.00 | 3.3% | 571.4% | US$14.0b | US$33.13 | PB32x | E-2.7% | n/a | Pharmaceuticals & Biotech | ||
VWS | DKK 98.66 | 1.9% | -54.1% | DKK 99.6b | DKK 163.72 | PE272.1x | E43.4% | n/a | Capital Goods | ||
A005490 | ₩256,000.00 | -2.7% | -48.7% | ₩19.6t | ₩440,000.00 | PE14.6x | E28.3% | 3.9% | Materials | ||
KCHOL | ₺184.70 | 0% | 30.7% | ₺467.9b | ₺283.82 | PE26.8x | E49.3% | 4.3% | Capital Goods | ||
A028260 | ₩117,600.00 | 1.6% | -9.2% | ₩19.4t | ₩187,647.06 | PE9.2x | E10.1% | 2.2% | Capital Goods | ||
PKN | zł46.51 | -1.2% | -29.6% | zł54.0b | zł73.27 | PE14.4x | E17.5% | 8.9% | Energy |